These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6241218)

  • 1. [Clofezone and oxyphenbutazone excluded from dental use].
    Tamura T
    Nihon Shika Ishikai Zasshi; 1984; 37(4):391-5. PubMed ID: 6241218
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of clofezone (pans) in oral surgery].
    Ogawa K; Oguchi J; Okada S
    Shikai Tenbo; 1978; 51(2):385-9. PubMed ID: 161230
    [No Abstract]   [Full Text] [Related]  

  • 3. [Animal experiment studies on the effect of intra-articular injections of antiphlogistic-antirheumatic agents on articular cartilage in vivo].
    Kalbhen DA; Schauer M; Wentsche B
    Z Rheumatol; 1978; 37(11-12):380-94. PubMed ID: 153678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug reactions. XII. Cutaneous reactions to anti-rheumatic drugs.
    Almeyda J; Baker H
    Br J Dermatol; 1970 Dec; 83(6):707-11. PubMed ID: 4250591
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind comparison of niflumic acid with phenylbutazone, oxyphenylbutazone and placebo in the treatment of osteoarthrosis.
    El-Mehairy MM; Shaker A; Bahgat NE; Hamza S; Salam MS
    Rheumatol Rehabil; 1974 Nov; 13(4):198-203. PubMed ID: 4614368
    [No Abstract]   [Full Text] [Related]  

  • 6. Withdrawal of oxyphenbutazone: what about phenylbutazone?
    Biron P
    CMAJ; 1986 May; 134(10):1119-20. PubMed ID: 3697857
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenylbutazone and oxyphenbutazone: time to call a halt.
    Drug Ther Bull; 1984 Jan; 22(2):5-6. PubMed ID: 6692755
    [No Abstract]   [Full Text] [Related]  

  • 8. A compliance study in general practice of patients switched from phenylbutazone and oxyphenbutazone to naproxen and other non-steroidal anti-inflammatory drugs.
    Dickson DJ; English JR
    Curr Med Res Opin; 1982; 8(1):61-6. PubMed ID: 6980773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenylbutazone, oxyphenbutazone labeling revised.
    FDA Drug Bull; 1984 Dec; 14(3):23-4. PubMed ID: 6526172
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pyrasanone in the treatment of rheumatism].
    Pellegrini P; Colamussi V; Trotta F; Scaramelli M; Bazzanini G
    Minerva Med; 1975 Oct; 66(67):3509-33. PubMed ID: 1103007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generalized pustular psoriasis precipitated by phenylbutazone and oxyphenbutazone.
    Reshad H; Hargreaves GK; Vickers CF
    Br J Dermatol; 1983 Jul; 109(1):111-3. PubMed ID: 6860567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylbutazone, oxyphenbutazone and aplastic anaemia.
    Böttiger LE
    Br Med J; 1977 Jul; 2(6081):265. PubMed ID: 884472
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: Fixed skin eruption caused by oxyphenbutazone with cross-reactivity to phenylbutazone.
    Pandhi RK; Dedi TR
    Arch Dermatol; 1975 Jan; 111(1):131. PubMed ID: 1119818
    [No Abstract]   [Full Text] [Related]  

  • 14. Contact sensitivity to oxyphenbutazone (Tanderil) and cross-sensitivity to phenylbutazone (Butazolidine).
    Krook G
    Contact Dermatitis; 1975 Dec; 1(6):385-6. PubMed ID: 139265
    [No Abstract]   [Full Text] [Related]  

  • 15. Fixed drug eruption to oxyphenbutazone and phenylbutazone.
    Nayyar KC; Pasricha JS
    Dermatologica; 1972; 144(4):214-6. PubMed ID: 5076722
    [No Abstract]   [Full Text] [Related]  

  • 16. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone.
    Inman WH
    Br Med J; 1977 Jun; 1(6075):1500-5. PubMed ID: 871632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contact sensitivity to oxyphenbutazone (Tanderil) and cross-sensitivity to phenylbutazone (Butazolidin).
    Krook G
    Contact Dermatitis; 1975 Aug; 1(4):262. PubMed ID: 139243
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol--Part I.
    Chaplin S
    Adverse Drug React Acute Poisoning Rev; 1986; 5(2):97-136. PubMed ID: 3529881
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-inflammatory agents in dentistry].
    Lorber CG
    ZWR; 1974 Aug; 83(16):820-2, 824 contd. PubMed ID: 4528866
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenylbutazone and oxyphenbutazone.
    Med Lett Drugs Ther; 1973 Apr; 15(9):40. PubMed ID: 4704701
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.